Lendalizumab (anti-Complement C5) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191930-100ΜG / 100ΜG
CAS:2210314-30-8
Lendalizumab (anti-Complement C5) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191930-10MG / 10MG
CAS:2210314-30-8
Lendalizumab (anti-Complement C5) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191930-1MG / 1MG
CAS:2210314-30-8
Lendalizumab (anti-Complement C5) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191930-5MG / 5MG
CAS:2210314-30-8
Netakimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC)
AB191931-100ΜG / 100ΜG
CAS:1796570-08-5
Netakimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC)
AB191931-10MG / 10MG
CAS:1796570-08-5
Netakimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC)
AB191931-1MG / 1MG
CAS:1796570-08-5
Netakimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC)
AB191931-5MG / 5MG
CAS:1796570-08-5
Xeligekimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191932-100ΜG / 100ΜG
CAS:2382921-73-3
Xeligekimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191932-10MG / 10MG
CAS:2382921-73-3
Xeligekimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191932-1MG / 1MG
CAS:2382921-73-3
Xeligekimab (anti-IL-17A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191932-5MG / 5MG
CAS:2382921-73-3
Navivumab (anti-HA) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191936-100ΜG / 100ΜG
CAS:1443004-16-7
Navivumab (anti-HA) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191936-10MG / 10MG
CAS:1443004-16-7
Navivumab (anti-HA) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191936-1MG / 1MG
CAS:1443004-16-7
Navivumab (anti-HA) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191936-5MG / 5MG
CAS:1443004-16-7
Duligotuzumab (anti-EGFR&HER3) ExactAb™, Validated, Low Endotoxin, Carrier Free, Azide Free, 重組, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB191943-100ΜG / 100ΜG
CAS:1314238-96-4
Duligotuzumab (anti-EGFR&HER3) ExactAb™, Validated, Low Endotoxin, Carrier Free, Azide Free, 重組, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB191943-10MG / 10MG
CAS:1314238-96-4
Duligotuzumab (anti-EGFR&HER3) ExactAb™, Validated, Low Endotoxin, Carrier Free, Azide Free, 重組, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB191943-1MG / 1MG
CAS:1314238-96-4
Duligotuzumab (anti-EGFR&HER3) ExactAb™, Validated, Low Endotoxin, Carrier Free, Azide Free, 重組, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB191943-5MG / 5MG
CAS:1314238-96-4
Stamulumab (anti-Myostatin) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191951-100ΜG / 100ΜG
CAS:705287-60-1
Stamulumab (anti-Myostatin) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191951-10MG / 10MG
CAS:705287-60-1
Stamulumab (anti-Myostatin) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191951-1MG / 1MG
CAS:705287-60-1
Stamulumab (anti-Myostatin) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191951-5MG / 5MG
CAS:705287-60-1
Keliximab (anti-CD4) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191955-100ΜG / 100ΜG
CAS:174722-30-6
Keliximab (anti-CD4) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191955-10MG / 10MG
CAS:174722-30-6
Keliximab (anti-CD4) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191955-1MG / 1MG
CAS:174722-30-6
Keliximab (anti-CD4) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191955-5MG / 5MG
CAS:174722-30-6
Minretumomab (anti-TAG-72) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191957-100ΜG / 100ΜG
CAS:195189-17-4
Minretumomab (anti-TAG-72) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191957-10MG / 10MG
CAS:195189-17-4
Minretumomab (anti-TAG-72) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191957-1MG / 1MG
CAS:195189-17-4
Minretumomab (anti-TAG-72) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB191957-5MG / 5MG
CAS:195189-17-4
Suptavumab (anti-RSV-F ) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191964-100ΜG / 100ΜG
CAS:1629615-23-1
Suptavumab (anti-RSV-F ) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191964-10MG / 10MG
CAS:1629615-23-1
Suptavumab (anti-RSV-F ) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191964-1MG / 1MG
CAS:1629615-23-1
Suptavumab (anti-RSV-F ) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191964-5MG / 5MG
CAS:1629615-23-1
Brolucizumab (anti-VEGFA) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191965-100ΜG / 100ΜG
CAS:1531589-13-5
Brolucizumab (anti-VEGFA) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB191965-10MG / 10MG
CAS:1531589-13-5